New technology also can be used to turn off peanut and other food allergies
In an entirely new approach to treating asthma and allergies, a biodegradable nanoparticle acts like a Trojan horse, hiding an allergen in a friendly shell, to convince the immune system not to attack it, according to new Northwestern Medicine research. As a result, the allergic reaction in the airways is shut down long- term and an asthma attack prevented.
The technology can be applied to food allergies as well. The nanoparticle is currently being tested in a mouse model of peanut allergy, similar to food allergy in humans.
“The findings represent a novel, safe and effective long-term way to treat and potentially ‘cure’ patients with life-threatening respiratory and food allergies,” said senior author Stephen Miller, the Judy Gugenheim Research Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine. “This may eliminate the need for life-long use of medications to treat lung allergy.”
It’s the first time this method for creating tolerance in the immune system has been used in allergic diseases. The approach has been used in autoimmune diseases including multiple sclerosis and celiac disease in previous preclinical Northwestern research.
The asthma allergy study was in mice, but the technology is progressing to clinical trials in autoimmune disease. The nanoparticle technology is being developed commercially by Cour Pharmaceuticals Development Co., which is working with Miller to bring this new approach to patients. A clinical trial using the nanoparticles to treat celiac disease is in development.
The new study on nanoparticles treating asthma was published April 18 in the Proceedings of the National Academy of Sciences.
“It’s a universal treatment,” Miller said. “Depending on what allergy you want to eliminate, you can load up the nanoparticle with ragweed pollen or a peanut protein.”
The nanoparticles are composed of an FDA-approved biopolymer called PLGA that includes lactic acid and glycolic acid.
Also a senior author is Lonnie Shea, adjunct professor of chemical and biological engineering at Northwestern’s McCormick School of Engineering and of obstetrics and gynecology at Feinberg, and chair of biomedical engineering at the University of Michigan.
When the allergen-loaded nanoparticle is injected into the bloodstream of mice, the immune system isn’t concerned with it because it sees the particle as innocuous debris. Then the nanoparticle and its hidden cargo are consumed by a macrophage, essentially a vacuum-cleaner cell.
“The vacuum-cleaner cell presents the allergen or antigen to the immune system in a way that says, ‘No worries, this belongs here,’” Miller said. The immune system then shuts down its attack on the allergen, and the immune system is reset to normal.
The allergen, in this case egg protein, was administered into the lungs of mice who have been pretreated to be allergic to the protein and already had antibodies in their blood against it. So when they were re-exposed to it, they responded with an allergic response like asthma. After being treated with the nanoparticle, they no longer had an allergic response to the allergen.
The approach also has a second benefit. It creates a more normal, balanced immune system by increasing the number of regulatory T cells, immune cells important for recognizing the airway allergens as normal. This method turns off the dangerous Th2 T cell that causes the allergy and expands the good, calming regulatory T cells.
The Latest on: Nanoparticles asthma allergies
via Google News
The Latest on: Nanoparticles asthma allergies
- Asthma Inhaler Device Market Size Is Expected to Grow at a CAGR of 5.2% By 2023 | Share Analysis, Future Growth and Global Industry Trendson October 30, 2019 at 4:37 am
Also, the key factors for asthma inhaler devices market progress are the existence of a huge population with numerous types of allergy conditions and widespread use of respiratory accessories and ...
- New treatment may reverse celiac diseaseon October 21, 2019 at 11:08 pm
Beyond celiac disease, the finding sets the stage for the technology—a nanoparticle containing the antigen triggering the allergy or autoimmune disease—to treat a host of other diseases and allergies ...
- Growing up on farm with animals may half risk of asthma and allergies, suggests studyon June 18, 2019 at 12:37 am
Earlier research has shown that growing up on a farm with animals may as much as half the risk of asthma and allergies. The protective effect is thought to be attributable to the diverse microbial ...
- Global Asthma Drugs Market 2019 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast 2025on May 31, 2019 at 6:25 am
The disease is believed to be caused by genetic as well as environmental factors. The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma ...
- May 2019 Nanolecture Series Eventon May 22, 2019 at 5:00 pm
Allergies and allergic asthma can also result from several allergens that people are exposed to in daily life such as house dust mite allergens. One way of potentially combatting allergic asthma is ...
- Animal study shows how to retrain the immune system to ease food allergieson February 20, 2018 at 4:00 pm
A test of this type was attempted as an asthma therapy, but it required a massive dose to the lungs and was ineffective. In their experiment with the peanut-allergy mice, St. John and colleagues ...
- How do eye drops help kids with allergies?on January 17, 2018 at 4:00 pm
American College of Allergy, Asthma, and Immunology. Digital Journal of Ophthalmology ... Model," "Lazy Eye Treatment Beyond Patches and Daily Drops," "Expert Develops Nanoparticle Drug Delivery ...
- Did researchers find a cure for allergies and asthma?on December 11, 2017 at 6:14 pm
When they were exposed, they had an asthma-like allergic reaction. After being treated with the nanoparticle, they no longer had a reaction when exposed to the allergen. Researchers are now conducting ...
- Outstanding animal studies in allergy I. From asthma to food allergy and anaphylaxison October 3, 2017 at 5:00 pm
Purpose of review Animal models published within the past 18 months on asthma, food allergy and ... Oral treatment of peanut-allergic C3H/HeJ mice with CpG/peanut-poly(lactic-co-glycolic acid) ...
- Nanoparticle acts like Trojan horse to halt asthmaon April 18, 2016 at 3:56 pm
In a new approach to treating asthma and allergies, a biodegradable nanoparticle acts like a Trojan horse, hiding an allergen in a friendly shell, to convince the immune system not to attack it, ...
via Bing News